Stai navigando con un browser obsoleto. per favore aggiorna il tuo browser per migliorare la tua esperienza e la tua sicurezza.

CDP Venture Capital
Maglie (LE) Life Science

Bio Aurum

Bio Aurum spearheads the medical research and development of nature-based treatments for a range of neurodegenerative diseases. The initial focus is on exploiting the naturally occurring bioactive molecules of saffron believed to target defined pathogenic pathways in Alzheimer’s and Parkinson’s diseases. Pipeline development is ICH-compliant and based on proprietary technology.
Bio Aurum combines a scientific approach with stringent clinical validation to advance medicine and improve health through nature.

The ecosystem supporting innovation in Italy